Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9648 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8954 |
High Similarity |
NPD7075 |
Discontinued |
0.894 |
High Similarity |
NPD6801 |
Discontinued |
0.8933 |
High Similarity |
NPD4380 |
Phase 2 |
0.8889 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8882 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8882 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8881 |
High Similarity |
NPD1510 |
Phase 2 |
0.8851 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8828 |
High Similarity |
NPD1549 |
Phase 2 |
0.8824 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8819 |
High Similarity |
NPD2796 |
Approved |
0.8805 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD1512 |
Approved |
0.8658 |
High Similarity |
NPD6799 |
Approved |
0.8627 |
High Similarity |
NPD7411 |
Suspended |
0.8601 |
High Similarity |
NPD1240 |
Approved |
0.859 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD3817 |
Phase 2 |
0.8571 |
High Similarity |
NPD1934 |
Approved |
0.8533 |
High Similarity |
NPD1511 |
Approved |
0.8526 |
High Similarity |
NPD3882 |
Suspended |
0.8516 |
High Similarity |
NPD7819 |
Suspended |
0.8516 |
High Similarity |
NPD2801 |
Approved |
0.85 |
High Similarity |
NPD6166 |
Phase 2 |
0.85 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.85 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8483 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8442 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8428 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8389 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8366 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8354 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8322 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8291 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8272 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8253 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8253 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8231 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8228 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8212 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8171 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8146 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8144 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8129 |
Intermediate Similarity |
NPD920 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8117 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8117 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8117 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8082 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8072 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8067 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8067 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7976 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7974 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD919 |
Approved |
0.7959 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7959 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7886 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7886 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7881 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7829 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7829 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7823 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7811 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7797 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7763 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.774 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7718 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7708 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7687 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7682 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7682 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7628 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7619 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7593 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7571 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD2403 |
Approved |
0.75 |
Intermediate Similarity |
NPD943 |
Approved |
0.75 |
Intermediate Similarity |
NPD5710 |
Approved |
0.75 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7452 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7451 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7396 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7386 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7383 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7383 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7341 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7325 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7325 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD3225 |
Approved |
0.731 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7297 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7285 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7246 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD37 |
Approved |
0.7229 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7202 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7202 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7197 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD9545 |
Approved |
0.719 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7189 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7189 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7189 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7186 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7171 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7169 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7166 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7115 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7114 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7105 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD17 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7074 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7074 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7074
|
Intermediate Similarity |
NPD7696 |
Phase 3 |